Results 1 to 10 of about 1,076 (197)

The Natural History of X-Linked Lymphoproliferative Disease (XLP1): Lessons from a Long-Term Survivor [PDF]

open access: yesCase Reports in Immunology, 2020
X-linked lymphoproliferative disease (XLP1) is a rare primary immunodeficiency characterized by EBV-triggered immune dysregulation, lymphoproliferation, dysgammaglobulinemia, and lymphoma.
Yike Jiang   +6 more
doaj   +3 more sources

Immune Dysfunction in Tourette Syndrome [PDF]

open access: yesBehavioural Neurology, 2013
The association between immunity and neurodevelopmental disorders has been extensively investigated in autism, suggesting a potential involvement of both cellular and humoral immunity in the establishment of synaptic connectivity modulation during ...
Ishraga Elamin   +2 more
doaj   +3 more sources

Exon skipping caused by a complex structural variation in SH2D1A resulted in X‐linked lymphoproliferative syndrome type 1 [PDF]

open access: yesMolecular Genetics & Genomic Medicine, 2022
Background X‐linked lymphoproliferative syndrome type 1 (XLP1) is a rare primary immunodeficiency disorder characterized by severe immune dysregulation often after viral infection. It is caused by hemizygous mutations in the X‐linked SH2D1A gene.
Liwen Wu   +5 more
doaj   +3 more sources

Case Report: DOCK8 Deficiency Without Hyper-IgE in a Child With a Large Deletion [PDF]

open access: yesFrontiers in Pediatrics, 2021
Autosomal recessive (AR) DOCK8 deficiency is a well-known actinopathy, a combined primary immune deficiency with impaired actin polymerization that results in altered cell mobility and immune synapse.
Edna Venegas-Montoya   +8 more
doaj   +2 more sources

Association of severe myoclonic epilepsy of infancy (SMEI) with probable autoimmune lymphoproliferative syndrome-variant [PDF]

open access: yesLa Pediatria Medica e Chirurgica, 2014
The paper reported on a case of severe myoclonic epilepsy of infancy (SMEI) associated with a probable autoimmune lymphoproliferative syndrome variant (Dianzani autoimmune lymphoproliferative disease) (DALD).
A. Berio, G. Mangiante, A. Piazzi
doaj   +5 more sources

Acrodermatitis enteropathica with dysgammaglobulinemia [PDF]

open access: bronzePediatric Research, 1971
In 1942 Danbolt and Closs described the association of diarrhea, eczematoid rash and alopecia. These physical findings constitute the triad essential for the diagnosis of this autosomal recessive disease. The demonstration of the efficacy of Diodoquin therapy in this otherwise fatal disease was by Dallaha and Lorincz in 1953.
O Rennert   +3 more
openaire   +2 more sources

Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP [PDF]

open access: yesFrontiers in Genome Editing, 2022
X-linked lymphoproliferative disease is a rare inherited immune disorder, caused by mutations or deletions in the SH2D1A gene that encodes an intracellular adapter protein SAP (Slam-associated protein).
Benjamin C. Houghton   +15 more
doaj   +3 more sources

Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression [PDF]

open access: yesAutops Case Rep, 2022
Lymphoplasmacyte-rich meningioma (LPRM) is one of the rarest variants of grade I meningiomas. It can be clinically associated with prominent peripheral blood abnormalities, anemia, and/or various gammopathy, which usually disappear after surgical removal
Davide Taietti   +7 more
core   +3 more sources

A Novel De Novo NFKBIA Missense Mutation Associated to Ectodermal Dysplasia with Dysgammaglobulinemia. [PDF]

open access: goldGenes (Basel), 2022
Chear CT   +9 more
europepmc   +3 more sources

Multifaceted roles of IKZF1 gene, perspectives from bench to bedside [PDF]

open access: yesFrontiers in Oncology
The IKZF1 gene encodes a transcription factor that belongs to the family of zinc-finger DNA-binding proteins associated with chromatin remodeling. The protein product, IKAROS, had been proved to regulate lymphopoiesis. Subsequent mouse model studies have
Lin Feng, Hang Zhang, Ting Liu
doaj   +2 more sources

Home - About - Disclaimer - Privacy